Navigation Links
Peptide Machines, Inc. Introduces New High-Quality, Cost-Efficient, Fully Automated Multiple Peptide Synthesizer with Preactivation
Date:8/23/2013

San Diego, CA (PRWEB) August 23, 2013

Discovery-4 is a 4-vessel peptide synthesizer designed to overcome the shortcomings and unnecessary complexity of existing synthesizers. The unique design prevents any precipitation, clogged lines, and overfills so typical of other instruments. The use of stock solutions of AA's eliminates the need for pre-fill cartridges or barcoding. The Discovery-4 has a preactivation vessel for every reaction vessel, which allows the synthesis of excellent quality peptides with a single coupling protocol.

The instrument's inherent flexibility for reagent set-up makes Discovery-4 very effective for both small and large scale synthesis from 0.05 mmol to 3 mmol. The system's precise metering pump delivery, patented solvent measuring device, and drastic washes reduction, cuts reagent and solvent consumption in half, thus reducing cost and minimizing waste. Discovery-4 utilizes 30, 60 and 100 ml glass reactors with removable filters. Each reactor can run independently with different scales and protocols.

The easy to use powerful software allows the user to effortlessly import sequences from USB, assign protocols to sequences, and sequences to reaction vessels. The calculation table, which is generated, provides the quantity of reagents required, allowing the user to very quickly go from an idea to execution.

The small footprint and fully ventilated hood make Discovery-4 suitable for any size peptide lab. With all this and more, the Discovery-4 is an ideal tool for R&D, process optimization, and peptide production.

For more information please visit http://www.peptidemachines.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051115.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
2. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
3. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
4. New Book Chapter from CEM on Microwave Peptide Synthesis
5. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
7. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
8. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
9. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
10. Small peptide ameliorates autoimmune skin blistering disease in mice
11. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015 Oxford Finance LLC ("Oxford"), a ... sciences and healthcare services companies, today announced the closing ... with Celula, Inc., a diagnostic testing company focused on ... patient care and improved outcomes.  Proceeds of the loan ... the commercialization of its products in the U.S. and ...
(Date:4/30/2015)... April 30, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 7, 2015 after the close of the U.S. financial ... webcast on Thursday, May 7, 2015 at 4:30 p.m. ... and recent corporate developments. For both "listen-only" ...
(Date:4/30/2015)... SureClinical, a leader in cloud-based health ... joined SureClinical’s executive team as Chief Financial Officer. ... executive with over 25 years in leadership roles ranging ... Ms. Morris joins SureClinical from Marrone Bio Innovations (MBI), ... of MBI from its founding in 2006 until 2011, ...
(Date:4/29/2015)... (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the ... year-end financial statements and MD&A have been filed on SEDAR ( www.sedar.com ... 2014 , 2013 Revenue 3,968 , 5,121 ... , 1,703 , 2,231 , 5,866 Operating  ... , 4,562 Ebitda* 92 , 418 , ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... EXTON, Pa., Feb. 28, 2012 ViroPharma Incorporated (Nasdaq: ... fourth quarter and year ended December 31, 2011. ... in annual net product sales, including $251 million in net ... in net sales of Vancocin® (Vancomycin Hydrochloride Capsules, USP); ...
... NOVATO, Calif., Feb. 28, 2012 Ultragenyx Pharmaceutical ... for rare and ultra-rare genetic disorders, today announced ... has granted orphan drug designation for UX003 for ... an extremely rare autosomal recessive lysosomal storage disorder ...
... Verenium Corporation (Nasdaq: VRNM ), a leading ... high-performance enzymes, today announced that it will release ... 5, 2012 at 8:00 a.m. ET. In conjunction with the ... webcast on Monday, March 5 at 8:30 a.m. ET. ...
Cached Biology Technology:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 12Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 2Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 3Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results 2Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results 3
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
(Date:3/23/2015)... -- SoundView Technology Group issues a new research update following ... smart wallet. SoundView was one of the selected user groups to ... Wocket in multiple scenarios and outlets. Soundview ... making both debit and credit card payments.  ... company meets their plans in 2015, it would push our ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... of Appeals has overturned an August 2010 ban on federal ... broader exploration of how stem cells function and how they ... incurable diseases. The ruling has been welcomed by the ... and by the nation,s top researchers in the field, including ...
... 27, 2011 According to the Centers for Disease Control ... more likely to die from diabetes than someone living in ... parts of the United States. Now, a group of seven ... change those health disparities and improve health through the creation ...
... A gene therapy approach using a protein called ... of age-related macular degeneration (AMD), according to a new ... of Medicine. Led by senior author Rajendra Kumar-Singh, PhD, ... delivered by a gene therapy approach significantly reduced the ...
Cached Biology News:US Appeals Court opens federal funding for stem cell research 2Network created to address obesity, chronic health issues in Appalachian region 2Network created to address obesity, chronic health issues in Appalachian region 3Gene therapy shows promise against age-related macular degeneration 2
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Biology Products: